Status:
COMPLETED
COVID-19 Quarantine on Musculoskeletal Status in Hemophilia
Lead Sponsor:
Investigación en Hemofilia y Fisioterapia
Conditions:
Hemophilia Arthropathy
Eligibility:
MALE
18-65 years
Brief Summary
Background. The recurrence of hemarthrosis in patients with congenital coagulopathies favors the development of a progressive, degenerative and intra-articular lesion (hemophilic arthropathy) that mai...
Eligibility Criteria
Inclusion
- Patients with medical diagnosis of hemophilia A or hemophilia B
- Patients over 18 years of age
- Patients in a prophylactic or on demand regimen with factor VIII / factor IX concentrates
- Patients that have accepted the informed consent document.
Exclusion
- Patients with neurological or cognitive disorders that prevent the comprehension of the questionnaires
- Patients without capacity to walk autonomously or with orthosis
- Patients without access to digital media to complement the measuring instruments.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 29 2020
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04491318
Start Date
July 1 2020
End Date
July 29 2020
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European University of Madrid
Madrid, Spain, 28670